Wikidata

(Q40176252)

English

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro

scientific article published on February 2007

In more languages

Statements

title
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17268817
retrieved
18 September 2017
author
Judy Dering
series ordinal
2
object named as
Judy Dering
0 references
author name string
Richard S Finn
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17268817
retrieved
18 September 2017
Charles Ginther
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17268817
retrieved
18 September 2017
Cindy A Wilson
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17268817
retrieved
18 September 2017
Padraic Glaspy
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
17268817
retrieved
18 September 2017
Nishan Tchekmedyian
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
17268817
retrieved
18 September 2017
Dennis J Slamon
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
17268817
retrieved
18 September 2017
publication date
1 February 2007
1 reference
stated in
Europe PubMed Central
PubMed ID
17268817
retrieved
18 September 2017
page(s)
319-326
1 reference
stated in
Europe PubMed Central
PubMed ID
17268817
retrieved
18 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40176252&oldid=1888295884"